Skip to main content

Vanda Pharmaceuticals Inc.

VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001347178

No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Vanda Pharmaceuticals Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of VNDA: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders174178+4
Shares55.9M55.1M−849.1K (−1.5%)
Value$610.6M$544.1M−$66.5M (−10.9%)

New holders (26)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Sold out (22)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.